Trending...
- Long Beach Health Department Confirms Measles Case Linked to International Travel
- California: Here's how Trump's illegal military deployment weakens firefighting resources – already strained by his dangerous U.S. Forest Service cuts
- The Nap Time Show Joins OnStage PLUS Television Network in Exciting New Content Partnership
MILPITAS, Calif. , June 18, 2025 ~ Galaxy Therapeutics, a leading medical device company specializing in the treatment of brain aneurysms, has announced the appointment of Dr. Michael Alexander as their new Chief Medical Officer. With over two decades of experience in neurosurgery and clinical research, Dr. Alexander brings a wealth of knowledge and expertise to the company.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
- KeysCaribbean Vacation Home Rentals Offers Last-Minute Booking Discount of 15 Percent
- California: Governor Newsom proclaims Juneteenth Day of Observance
- Court Denies Santa Barbara County's Motion To Dismiss Over Recycling Facility Dispute
- purelyIV Blog Named One of the Top 45 IV Therapy Blogs by Feedspot
- purelyIV Launches Mobile Iron Infusion Therapy for Patients with Iron Deficiency Anemia
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
- Smile Makers Dental Care Introduces FP1: East Bay's First Robotic-Assisted Full-Arch Implant Solution for Natural, Fixed Smiles
- BTM INDUSTRIAL SPONSORS PEDAL TO THE RESCUE'S CROSS-COUNTRY RIDE FOR THE LA FIRE DEPARTMENT FOUNDATION
- DCAS College opens new Representative Office in Malaysian Capital Kuala Lumpur
- Mike Diamond Plumbing, HVAC & Electrical Offers Free House Call on Plumbing Repairs in Anaheim, CA
- Ray Buffer Menaces as "Frank Beatty" in Sci-Fi Western The Lord of All Future Space
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
Filed Under: Business
0 Comments
Latest on The Californer
- National Aircraft Detailers & Cleaners Launches Premium Aircraft Detailing Services in California
- Bowman Line Striping Opens New Commercial Parking Lot Asphalt Maintenance Company Near LA
- California: Governor Newsom issues emergency proclamation to help the City of Malibu recover from Franklin Fire
- As Sober.Buzz Community Explodes It's Growth Globally it is Announcing "Spreading the Good BUZZ" Podcast Hosted by Josh Case Debuting July 7th
- Coming Soon: The Cottages at Powell Park Offer a Rare Blend of Charm, Convenience, and Community in Raleigh
- California: After celebrating State Parks Week, Newsom administration calls out federal assault on public lands
- CredHub and All County Property Management Franchise Corp. Partner to Empower Franchisees with Rental Payment Credit Reporting Solutions
- California breaks ground on two affordable housing communities in San Francisco — including for local school district, community college employees
- Cali War Dominates The WFA! Road To The Champion
- Pregis Shares 2024 Sustainability Report Highlighting Progress in Circular Product Innovation, Emissions Accountability, and Global Impact
- It's Summertime and the SLAYING is Easy: GNOME SICK: 7 SLAYS TIL MITHRAS
- Initial Order Received from Vietnamese Maritime Security and Defense Services for Advanced Video Compression Solution: RMX; Stock Symbol: RMXI
- HOTEL DEL CORONADO ANNOUNCES COMPLETION OF A MORE THAN $550 MILLION, MULTI-YEAR RESTORATION
- Keebos Launches New Universal Pearl Strap That Attaches to Any Phone Case
- Special Education School Celebrates Graduation
- Work 365 Launches Certified Provider Integration (CPI) Program to Help Distributors and CSPs Navigate Microsoft's Evolving Ecosystem
- Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine's Most Fundable Companies Competition
- Juneteenth.rocks California with Phillip E. Walker Leading the 4th Annual Rancho Cucamonga Juneteenth WALK plus a "Hapless Revenge" Movie Screening
- Bryckel Announces Seamless Integration with Rent Manager to Streamline Lease Abstraction
- California: Governor Newsom on Fox News: "Trump is trying to destroy our democracy. Do not let him"